Top Medical Equipment Brands Revolutionizing Healthcare

In an era where technology rapidly advances, the medical equipment industry plays a pivotal role in ensuring healthcare professionals have the tools they need to deliver exceptional patient care. This sector boasts a wide array of brands that stand out for their innovative solutions, reliability, and quality craftsmanship. From diagnostic imaging to surgical instruments, these brands continually push the boundaries to enhance medical practices worldwide. Interested in discovering which companies lead the pack in medical equipment manufacturing? Explore our detailed list below.

Illustration of medical equipment

Best brands of medical equipment in 2025

Medtronic

Medtronic is a leading producer of medical equipment, reclaiming its top position in 2024 with impressive full-year global revenues of $32.4 billion, a 4% increase from the previous year. The company's growth was driven by its Cardiovascular portfolio, which saw a 2.7% increase, Neuroscience therapies with a 5.0% increase, and the Medical Surgical segment with a 5.4% increase. Medtronic holds the highest share in the worldwide medical industry market with 8% and employs over 95,000 people across 150 countries, providing solutions for more than 70 health conditions. In 2024, Medtronic's medical surgical group reported total net sales of over $8.4 billion, with the U.S. market accounting for around $3.7 billion. The company's innovative products, such as those for atrial fibrillation treatments and diabetes devices, have significantly contributed to its market growth. For more insights on top medical device companies in the world in 2024, refer to this comprehensive list.

Johnson & Johnson

Johnson & Johnson is a leading global provider of medical devices, holding a significant market share of 6% in the global medical device industry as of 2024. The company operates in approximately 30% of the estimated global medical device market, which is projected to grow from $478.54 billion in 2024 to $673.16 billion by 2028. Johnson & Johnson's Medical Devices & Diagnostics segment generated $28.5 billion in sales in 2013, driven by ten $1 billion-plus platforms. The company's strong presence in emerging markets, where the medical device segment is growing three-to-four times faster than in developed markets, further solidifies its market leadership. With a history dating back to 1886, Johnson & Johnson continues to innovate and expand its market presence through advanced technologies and strategic partnerships. You can find more information about their innovative products and customer-focused solutions on their official press release.

GE Healthcare

GE Healthcare is a leading global medical technology and life sciences company, renowned for its innovative and patient-focused technologies. Since its spin-off from General Electric in January 2023, GE Healthcare has posted impressive results, including a 5.4% year-over-year revenue increase to $4.82 billion in the third quarter of 2023, driven by higher demand for medical equipment following the COVID-19 pandemic. The company's Imaging and Patient Care Solutions segments saw significant growth, with a 5% and 9% increase in revenue, respectively. GE Healthcare serves over 1 billion patients annually and operates in over 100 countries, with a strong portfolio in PET, X-ray, CT, MRI, ECG, and Ultrasound machines. The company invests approximately $1 billion annually in R&D and has over 200 AI-enabled device authorizations in the US. For more information, visit their website.

Siemens Healthineers

Siemens Healthineers is a leading global medical technology company, renowned for its exceptional performance in diagnostic imaging and laboratory diagnostics. In the fiscal year 2024, the company achieved a record revenue of around 22.4 billion euros, marking the highest annual figure ever recorded. As the market leader in imaging, Siemens Healthineers holds more than 50% of the global market share and over 70% in the US. The company's acquisition of Varian Medical Systems has further solidified its position, with approximately 66,000 employees worldwide. Siemens Healthineers continues to innovate, focusing on AI-supported applications and digital offerings to enhance healthcare delivery. For detailed statistics on their global medical technology revenue, visit Statista.

Philips Healthcare

Philips Healthcare is a leading health technology company, renowned for its innovative medical solutions and strong market presence. In 2023, Philips Healthcare generated revenue of up to $18.75 billion, ranking it as the 7th top medical device company globally. The company holds significant market shares, with around 70% of its sales coming from its #1 or #2 positions in various markets, including image-guided therapy, monitoring, and ultrasound. Philips has a global footprint, operating in over 100 countries with approximately 70,000 employees, and has been 100% carbon-neutral in its operations since 2020. The company continues to invest heavily in R&D, with about 9% of its sales dedicated to research and development. For more detailed information, visit their Philips Healthcare website.

Boston Scientific

Boston Scientific is a leading producer of medical equipment, renowned for its innovative solutions and strong market presence. As of Q3 2024, the company holds a 4.70% market share in the Medical Equipment & Supplies industry and a 4.77% share in the broader Healthcare sector. Boston Scientific generated net sales of $4.209 billion in Q3 2024, representing a 19.4% growth on a reported basis. The company invests significantly in R&D, with $1.4 billion allocated annually, and treats over 37 million patients each year across 140 countries. With a global workforce of 48,000 employees and a portfolio of over 15,000 products, Boston Scientific continues to advance medical care through meaningful innovation.

Becton Dickinson

Becton Dickinson (BD) is a leading global medical technology company, renowned for its innovative medical devices, instrument systems, and reagents. In 2023, BD reported full-year revenues of $19.3 billion, marking a 2% increase, with significant growth across its BD Medical, BD Life Sciences, and BD Interventional segments. The company's revenue growth was driven by strong performances in the US and international markets, with a 6.3% and 7.6% increase respectively. BD's market share in the Medical Equipment & Supplies Industry stands at 2.17% as of Q3 2024, highlighting its competitive position. The company's recent acquisitions and product launches, such as the BD Alaris™ and FACSLyric™ Clinical Cell Analyzer, have contributed to its robust growth. For more insights into their financial success, read their detailed financial results.

Abbott Laboratories

Abbott Laboratories is a leading producer of medical equipment, notably driven by its robust growth in the medical devices segment, which saw a 13.3% organic sales increase in the third quarter of 2024. This growth was fueled by double-digit sales in catheters, cardiac-mapping products, and a 21% increase in its continuous glucose monitor unit. The company's partnership with Medtronic to develop a continuous glucose monitor compatible with Medtronic's insulin pumps also contributed to its strong performance. Abbott's total sales for the quarter reached approximately $10.6 billion, exceeding Wall Street expectations. The company's diverse portfolio includes products like FreeStyle Libre(r), Navitor(r), and TriClip(r), which have been key drivers of its success.

Stryker Corporation

Stryker Corporation is a global leader in medical technologies, impacting over 150 million patients annually with its innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine. The company holds significant market shares, including 35% in the worldwide reconstructive market, 50% in the MedSurg market, and 15% in the Neurotechnology and Spine market. With $20.5 billion in global sales in 2023 and $1.4 billion spent on R&D, Stryker continues to drive healthcare improvement. The company employs 52,000 people worldwide and owns approximately 12,900 patents globally. Stryker is listed on the New York Stock Exchange and is part of the S&P 500 index. For more information, visit the Stryker Corporation website.

Zimmer Biomet

Zimmer Biomet is a leading global medical technology company, renowned for its innovative orthopedic products and integrated digital technologies. As of 2023, the company holds significant market shares, with 41% in knee orthopedics and 27% in hip orthopedics. Zimmer Biomet's net sales in the United States alone amounted to over $4.2 billion from 2021 to 2023, while global sales reached $7.6 billion as of Q3 2024. The company operates in over 25 countries and sells products in more than 100 countries worldwide, with a market cap of $21.3 billion. Its products and solutions aim to restore mobility, alleviate pain, and improve the quality of life for patients globally. For more information about their products and solutions, visit their website.